Isenbruck Bösl Hörschler – Germany 2018
This pure patent attorney firm is very visible in pharmaceuticals and chemicals patents, the two main pillars of work. The patent attorneys are often seen in high-profile proceedings, e.g. for Hormosan concerning Truvada. But IBH already reacted two years ago to the upheavals in the pharmaceuticals industry and shifted capacities to other sectors. Since then, it has focused more on patents on the interface with electronics and mechanics, e.g. bioinformatics or medical technology. Unlike last year, IBP grew again with a new patent attorney.
Patent prosecution with an excellent reputation in the chemicals, pharmaceuticals and biotech sectors.
Dr. Raphael Bösl (“very positive experience with him filing biotech patents”, client), Wolfram Hörschler, Dr. Fritz Lahrtz, Dr. Stefan Féaux de Lacroix (all patent attorneys).
27 patent attorneys
IP activity focuses on patent prosecution with technical expertise in biotech/pharmaceuticals, chemicals, electronics, IT, mechanics and medical technology. Nullity and opposition suits. Infringement proceedings by patent attorneys.
Litigation: Shionogi against Merck regarding HIV drug; Hormosan concerning Truvada. Prosecution: filing, opposition suits and strategic portfolio management for BASF, Celanese, Lanxess, Robert Bosch, Roche Diagnostics, Sanofi-Pasteur.
Mannheim, Munich, Düsseldorf